BENZOTRIAZINONES AS VIRTUAL RING MIMICS OF ORTHO-METHOXYBENZAMIDES - NOVEL AND POTENT 5-HT3 RECEPTOR ANTAGONISTS

被引：27
作者：
KING, FD
DABBS, S
BERMUDEZ, J
SANGER, GJ
机构：
[1] SmithKline Beecham Pharmaceuticals, Coldharbour Road, Pinnacles Harlow, Essex
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 1990年 / 33卷 / 11期
关键词：
D O I：
10.1021/jm00173a002
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：2942 / 2944
页数：3
相关论文
共 17 条
  • [1] 5-HYDROXYTRYPTAMINE (5-HT3) RECEPTOR ANTAGONISTS .1. INDAZOLE AND INDOLIZINE-3-CARBOXYLIC ACID-DERIVATIVES
    BERMUDEZ, J
    FAKE, CS
    JOINER, GF
    JOINER, KA
    KING, FD
    MINER, WD
    SANGER, GJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (07) : 1924 - 1929
  • [2] 5-HYDROXYTRYPTAMINE (5-HT3) RECEPTOR ANTAGONISTS .2. 1-INDOLINECARBOXAMIDES
    BERMUDEZ, J
    DABBS, S
    JOINER, KA
    KING, FD
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (07) : 1929 - 1932
  • [3] PHARMACOLOGICAL PROPERTIES OF GR38032F, A NOVEL ANTAGONIST AT 5-HT3 RECEPTORS
    BUTLER, A
    HILL, JM
    IRELAND, SJ
    JORDAN, CC
    TYERS, MB
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1988, 94 (02) : 397 - 412
  • [4] FAKE C S, 1987, British Journal of Pharmacology, V91, p335P
  • [5] MDL-72222 - A POTENT AND HIGHLY SELECTIVE ANTAGONIST AT NEURONAL 5-HYDROXYTRYPTAMINE RECEPTORS
    FOZARD, JR
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1984, 326 (01) : 36 - 44
  • [6] SUBSTITUTED BENZAMIDES WITH CONFORMATIONALLY RESTRICTED SIDE-CHAINS .1. QUINOLIZIDINE DERIVATIVES AS SELECTIVE GASTRIC PROKINETIC AGENTS
    HADLEY, MS
    KING, FD
    MCRITCHIE, B
    TURNER, DH
    WATTS, EA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (12) : 1843 - 1847
  • [7] CONFORMATION-ACTIVITY RELATIONSHIP STUDY OF 5-HT3 RECEPTOR ANTAGONISTS AND A DEFINITION OF A MODEL FOR THIS RECEPTOR-SITE
    HIBERT, MF
    HOFFMANN, R
    MILLER, RC
    CARR, AA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (06) : 1594 - 1600
  • [8] HIBERT MF, 1988, ACTUAL CHIM THER, V16, P37
  • [9] KING F D, 1989, Drugs of the Future, V14, P875
  • [10] KING FD, 1989, Patent No. 315390
12